Pharmacokinetics and safety of glimepiride at clinically effective doses in diabetic patients with renal impairment

Diabetologia
B RosenkranzV Malerczyk

Abstract

The pharmacokinetics, efficacy and safety of glimepiride were investigated in a single- and a multiple-dose open study in patients with non-insulin-dependent diabetes mellitus and renal impairment and an initial creatinine clearance above 10 ml/ min. Patients were divided into three groups with creatinine clearance above 50 ml/min, 20-50 ml/min and under 20 ml/min. Fifteen fasting patients received a single dose of 3 mg glimepiride and serial blood and urine samples were taken over 24 h for pharmacokinetic and efficacy analyses. A further 16 patients received glimepiride over a 3-month period, an initial dose of 1 mg glimepiride being adjusted within the range 1 to 8 mg to achieve good glucose control. Pharmacokinetic evaluation was done on day 1 and after 3 months. Mean relative total clearance and mean volume of distribution of both single (41.6 ml/ min and 8.47 litres, respectively, when creatinine clearance was above 50 ml/min) and multiple doses of glimepiride increased in proportion to the degree of renal impairment (to 91.1 ml/min and 14.98 litres, respectively, when creatinine clearance was below 20 ml/min, single dose), whereas the terminal halflife and mean time remained unchanged. Lower relative total clearance and r...Continue Reading

Citations

Nov 29, 2012·Current Diabetes Reports·Ashley TherasseMark E Molitch
Jul 1, 1996·Diabetes Research and Clinical Practice·R RosskampE Draeger
Sep 11, 2004·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Yun-Kyoung SongChong-Kook Kim
Mar 2, 2002·Journal of Diabetes and Its Complications·Christoph Rosak
Jan 21, 2011·American Journal of Therapeutics·Arshag D Mooradian, Joe M Chehade
Apr 9, 2010·Seminars in Dialysis·Radica Z Alicic, Katherine R Tuttle
Jan 27, 2007·Vojnosanitetski pregled. Military-medical and pharmaceutical review·Dusan JovanovićMiodrag Jovanović
Dec 11, 2013·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Paul ArnoutsWim van Biesen
Jul 11, 2003·Clinical Therapeutics·Massimo Massi-Benedetti
Jan 9, 2010·Expert Opinion on Drug Metabolism & Toxicology·Vanessa J BriscoeStephen N Davis
May 5, 2001·Expert Opinion on Pharmacotherapy·A L McCall
Mar 7, 2013·Expert Opinion on Drug Metabolism & Toxicology·André J Scheen
Mar 3, 2012·Journal of Pharmaceutical Sciences·Jayabharathi VaidyanathanChandrahas G Sahajwalla
Jan 28, 2014·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Mark E Williams, Rajesh Garg
Feb 24, 2016·Journal of Diabetes and Its Complications·Clotilde MullerUNKNOWN CERRENE study group
Mar 7, 2014·Kidney International·Jean-Daniel LalauMarc E De Broe
Jan 8, 2013·The Medical Clinics of North America·Rajesh Garg, Mark E Williams
Oct 17, 2012·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·UNKNOWN National Kidney Foundation
Aug 4, 2015·Biological & Pharmaceutical Bulletin·Eun-Yeong KimKiho Lee
Aug 19, 2007·Diabetes & Metabolism·J F BlickléT Hannedouche
Aug 13, 2004·European Journal of Clinical Investigation·G SchernthanerK M Shaw
May 28, 2004·Pharmacotherapy·Mary T Korytkowski
Apr 21, 2016·The Medical Clinics of North America·Amisha WalliaMark E Molitch
Sep 14, 2010·Journal of Clinical Pharmacy and Therapeutics·G SultanaK K Pillai
Nov 9, 2004·Journal of Diabetes and Its Complications·Stephen N Davis
Dec 6, 2005·Diabetes Research and Clinical Practice·Kazuko SuzukiMasahiro Tohkin
Aug 19, 2015·Journal of Natural Science, Biology, and Medicine·Prasad Neerati
Oct 24, 2007·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Noah D LubowskyAnastassios G Pittas
Apr 17, 2003·European Journal of Clinical Pharmacology·A HolsteinE-H Egberts
Sep 19, 2002·The Journal of International Medical Research·K Thompson-CulkinM I Freed
Apr 10, 2010·British Journal of Haematology·Jeremy T S Sargent, Owen P Smith
Jan 2, 2001·Endocrine Reviews·S MatthaeiH U Häring

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Related Papers

Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme
M C Riddle
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme
B Rosenkranz
© 2021 Meta ULC. All rights reserved